- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Healthy potentially undervalued
Chinese Pharmaceuticals & Biotech Healthy potentially undervalued
Results
14
Companies which are potentially undervalued and in an acceptable financial position.
14 companies
Yunnan Baiyao GroupLtd
Market Cap: CN¥99.8b
Engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally.
000538
CN¥55.96
7D
0.1%
1Y
4.8%
Wuhan Keqian BiologyLtd
Market Cap: CN¥8.0b
Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.
688526
CN¥17.24
7D
1.4%
1Y
26.7%
Dong-E-E-JiaoLtd
Market Cap: CN¥32.3b
Research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods.
000423
CN¥50.33
7D
-1.5%
1Y
2.7%
Beijing Tongrentang
Market Cap: CN¥49.7b
Engages in the scientific research, production, distribution, and sale of Chinese medicines in China.
600085
CN¥36.22
7D
-0.5%
1Y
-0.2%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥52.1b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥31.21
7D
-1.4%
1Y
-4.9%
Imeik Technology DevelopmentLtd
Market Cap: CN¥54.8b
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.
300896
CN¥181.89
7D
-0.9%
1Y
8.8%
Zhejiang Jiuzhou Pharmaceutical
Market Cap: CN¥16.6b
Operates as contract development and manufacturing organization company in China and internationally.
603456
CN¥18.78
7D
3.4%
1Y
39.7%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥14.4b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥45.55
7D
-2.0%
1Y
1.7%
WuXi AppTec
Market Cap: CN¥285.9b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥97.80
7D
7.9%
1Y
143.2%
Tianjin Ringpu Bio-TechnologyLtd
Market Cap: CN¥10.4b
Engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products.
300119
CN¥22.78
7D
5.2%
1Y
73.0%
Hualan Biological Engineering
Market Cap: CN¥30.7b
A biopharmaceutical company, researches, develops, produces, and commercializes blood products, vaccines, and recombinant proteins in China and internationally.
002007
CN¥16.78
7D
1.0%
1Y
6.8%
Amoy Diagnostics
Market Cap: CN¥9.2b
Engages in the development and commercialization of diagnostics product for oncology in China and internationally.
300685
CN¥23.91
7D
2.3%
1Y
27.3%
Xiamen Amoytop Biotech
Market Cap: CN¥34.8b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥85.60
7D
0.7%
1Y
72.0%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥41.2b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥91.47
7D
-3.2%
1Y
67.3%